Rodríguez, Natalia http://orcid.org/0000-0002-9618-9383
Gassó, Patricia http://orcid.org/0000-0001-6930-3454
Martínez-Pinteño, Albert
Segura, Àlex-González
Mezquida, Gisela
Moreno-Izco, Lucia
González-Peñas, Javier http://orcid.org/0000-0002-3850-3012
Zorrilla, Iñaki
Martin, Marta
Rodriguez-Jimenez, Roberto
Corripio, Iluminada
Sarró, Salvador http://orcid.org/0000-0003-1835-2189
Ibáñez, Angela http://orcid.org/0000-0003-2751-0150
Butjosa, Anna http://orcid.org/0000-0001-5317-9508
Contreras, Fernando
Bioque, Miquel
Cuesta, Manuel-Jesús
Parellada, Mara
González-Pinto, Ana
Berrocoso, Esther http://orcid.org/0000-0003-0208-7472
Bernardo, Miquel http://orcid.org/0000-0001-8748-6717
Mas, Sergi http://orcid.org/0000-0003-3336-6298
Amoretti S, Silvia
Moren, Constanza
Stella, Carol
Gurriarán, Xaquin
Alonso-Solís, Anna
Grasa, Eva
Fernandez, Jessica
Gonzalez-Ortega, Itxaso
Casanovas, Francesc
Bulbuena, Antoni
Núñez-Doyle, Ágatha
Jiménez-Rodríguez, Olga
Pomarol-Clotet, Edith
Feria-Raposo, Isabel
Usall, Judith
Muñoz-Samons, Daniel
Ilundain, Jose L.
Sánchez-Torres, Ana Maria
Saiz-Ruiz, Jeronimo
López-Torres, Isabel
Nacher, Juan
De-la-Cámara, Concepción
Gutiérrez, Miguel
Sáiz, Pilar Alejandra
,
Article History
Received: 14 June 2021
Accepted: 1 February 2022
First Online: 27 April 2022
Competing interests
: A. Ibáñez has received research support from or served as speaker or advisor for Janssen-Cilag, Lundbeck, and Otsuka. A. Gonzalez-Pinto has received grants and served as consultant, advisor, or CME speaker for the following entities: Janssen-Cilag, Lundbeck, Otsuka, Pfizer, Sanofi-Aventis, Exeltis, the Spanish Ministry of Science and Innovation (CIBERSAM), the Ministry of Science (Carlos III Institute), and the Basque Government. J. Saiz-Ruiz has been as speaker for and on the advisory boards of Adamed, Lundbeck, Servier, Medtronic, Casen Recordati, Neurofarmagen, Otsuka, Indivior, Lilly, Schwabe, Janssen, and Pfizer, outside the submitted work. M. Bernardo has been a consultant for, received grant/research support and honoraria from, and been on the speakers/advisory board of ABBiotics, Adamed, Angelini, Casen Recordati, Janssen-Cilag, Menarini, Rovi, and Takeda. M. Bioque has been a consultant for, received grant/research support and honoraria from, and been on the speakers/advisory board of, has received honoraria from talks and/or consultancy of Adamed, Angelini, Ferrer, Janssen-Cilag, Lundbeck, Neuraxpharm, Otsuka, Pfizer, and Sanofi, and grants from Spanish Ministry of Health, Instituto de Salud Carlos III. M. Gutiérrez Fraile has been on the speakers/advisory board of Janssen-Cilag. Pilar A. Saiz has been a consultant to and/or has received honoraria or grants from Adamed, CIBERSAM, European Commission, Government of the Principality of Asturias, Instituto de Salud Carlos III, Janssen-Cilag, Lundbeck, Otsuka, Pfizer, Plan Nacional Sobre Drogas, and Servier. R. Rodriguez-Jimenez has been a consultant for, spoken in activities of, or received grants from Instituto de Salud Carlos III, Fondo de Investigación Sanitaria (FIS), Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid Regional Government (S2010/BMD-2422 AGES; S2017/BMD-3740), JanssenCilag, Lundbeck, Otsuka, Pfizer, Ferrer, Juste, Takeda, Exeltis, Casen-Recordati, and Angelini.